This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
pulmonary | disease | 1568 |
epithelial | cells | 703 |
acute | exacerbations | 422 |
mean | age | 352 |
viral | infections | 308 |
acute | exacerbation | 250 |
viral | infection | 243 |
immune | response | 222 |
- | cell | 174 |
immune | responses | 169 |
respiratory | disease | 167 |
inflammatory | response | 166 |
- | time | 161 |
severe | asthma | 160 |
primary | care | 159 |
bacterial | infection | 145 |
severe | copd | 143 |
- | risk | 134 |
human | lung | 133 |
- | copd | 128 |
chronic | lung | 117 |
respiratory | infections | 117 |
epithelial | cell | 108 |
inflammatory | cells | 102 |
high | risk | 101 |
respiratory | diseases | 100 |
bacterial | infections | 94 |
acute | lung | 87 |
severe | exacerbations | 87 |
lower | airway | 84 |
inflammatory | responses | 78 |
immune | cells | 78 |
human | airway | 75 |
- | year | 71 |
lower | airways | 69 |
clinical | data | 68 |
obstructive | lung | 67 |
acute | asthma | 65 |
respiratory | infection | 61 |
pulmonary | diseases | 60 |
high | levels | 58 |
acute | care | 57 |
- | cells | 54 |
chronic | diseases | 54 |
- | patient | 52 |
- | lung | 51 |
chronic | disease | 46 |
- | level | 44 |
human | disease | 44 |
higher | risk | 43 |
inflammatory | lung | 43 |
low | risk | 41 |
- | day | 38 |
- | effects | 38 |
- | group | 38 |
higher | levels | 38 |
other | studies | 38 |
pulmonary | infection | 38 |
severe | disease | 37 |
other | factors | 35 |
- | care | 33 |
positive | airway | 32 |
- | treatment | 31 |
- | response | 31 |
older | age | 29 |
- | patients | 29 |
clinical | studies | 28 |
high | level | 28 |
inflammatory | cell | 28 |
viral | exacerbations | 28 |
chronic | asthma | 27 |
inflammatory | diseases | 27 |
acute | copd | 26 |
human | cell | 26 |
medical | care | 26 |
chronic | airway | 25 |
inflammatory | effects | 25 |
old | copd | 25 |
such | patients | 25 |
older | patients | 24 |
normal | lung | 24 |
- | p | 23 |
- | years | 23 |
positive | cases | 23 |
clinical | care | 22 |
immune | cell | 22 |
lower | levels | 22 |
positive | result | 22 |
positive | results | 22 |
- | age | 21 |
low | levels | 21 |
- | infection | 20 |
different | lung | 20 |
severe | exacerbation | 19 |
other | risk | 19 |
other | patients | 19 |
mean | time | 19 |
inflammatory | effect | 18 |
more | patients | 18 |
acute | effects | 18 |
different | levels | 17 |
inflammatory | disease | 17 |
lower | lung | 17 |
other | cell | 16 |
primary | cells | 16 |
other | diseases | 16 |
severe | cases | 16 |
normal | day | 16 |
inflammatory | airway | 16 |
human | studies | 16 |
mean | ages | 16 |
bacterial | exacerbations | 15 |
such | infections | 15 |
medical | treatment | 14 |
severe | lung | 14 |
primary | lung | 14 |
other | lung | 14 |
mean | level | 14 |
lower | risk | 14 |
important | factor | 14 |
- | airway | 14 |
different | groups | 13 |
more | time | 13 |
pulmonary | exacerbations | 13 |
severe | patients | 13 |
other | groups | 12 |
pulmonary | infections | 12 |
significant | effect | 12 |
highest | levels | 12 |
clinical | factors | 12 |
more | studies | 11 |
positive | patients | 11 |
old | age | 11 |
obstructive | airway | 11 |
significant | risk | 11 |
mean | cell | 11 |
human | lungs | 11 |
clinical | study | 11 |
- | infections | 11 |
inflammatory | factors | 10 |
other | patient | 10 |
positive | group | 10 |
primary | airway | 10 |
human | diseases | 9 |
severe | infection | 9 |
other | day | 9 |
other | asthma | 9 |
mean | patient | 9 |
low | lung | 9 |
clinical | risk | 9 |
human | asthma | 9 |
higher | level | 9 |
different | time | 9 |
different | studies | 9 |
acute | infection | 9 |
- | factor | 9 |
inflammatory | asthma | 8 |
severe | infections | 8 |
severe | airway | 8 |
respiratory | risk | 8 |
positive | effect | 8 |
normal | lungs | 8 |
more | exacerbations | 8 |
different | age | 8 |
important | factors | 8 |
high | risks | 8 |
different | factors | 8 |
chronic | infection | 8 |
clinical | treatment | 8 |
clinical | cases | 8 |
human | cells | 8 |
lower | % | 7 |
severe | group | 7 |
pulmonary | exacerbation | 7 |
other | group | 7 |
older | studies | 7 |
old | patients | 7 |
non | copd | 7 |
low | level | 7 |
important | risk | 7 |
immune | factors | 7 |
human | airways | 7 |
different | diseases | 7 |
clinical | effects | 7 |
chronic | response | 7 |
different | treatment | 6 |
such | cases | 6 |
other | study | 6 |
other | cells | 6 |
normal | levels | 6 |
higher | exacerbation | 6 |
normal | cells | 6 |
different | responses | 6 |
common | risk | 6 |
common | diseases | 6 |
chronic | airways | 6 |
- | study | 6 |
- | days | 6 |
medical | patients | 5 |
significant | effects | 5 |
respiratory | patients | 5 |
respiratory | exacerbations | 5 |
respiratory | cells | 5 |
respiratory | care | 5 |
primary | treatment | 5 |
other | methods | 5 |
normal | airway | 5 |
primary | risk | 5 |
immune | diseases | 5 |
highest | risk | 5 |
different | cell | 5 |
clinical | response | 5 |
bacterial | airway | 5 |
- | methods | 5 |
- | groups | 5 |
- | asthma | 5 |
human | infection | 5 |
significant | airway | 4 |
positive | disease | 4 |
positive | effects | 4 |
respiratory | study | 4 |
severe | airways | 4 |
viral | exacerbation | 4 |
significant | results | 4 |
such | studies | 4 |
such | treatment | 4 |
mean | lung | 4 |
older | group | 4 |
inflammatory | treatments | 4 |
mean | airway | 4 |
different | days | 4 |
lower | level | 4 |
clinical | disease | 4 |
clinical | effect | 4 |
common | disease | 4 |
bacterial | exacerbation | 4 |
different | disease | 4 |
different | patient | 4 |
lower | asthma | 4 |
- | disease | 4 |
obstructive | airways | 3 |
primary | study | 3 |
obstructive | diseases | 3 |
old | patient | 3 |
other | airway | 3 |
other | copd | 3 |
other | treatment | 3 |
positive | response | 3 |
primary | method | 3 |
significant | disease | 3 |
pulmonary | cells | 3 |
pulmonary | level | 3 |
respiratory | airways | 3 |
significant | levels | 3 |
such | disease | 3 |
viral | disease | 3 |
viral | responses | 3 |
more | times | 3 |
normal | airways | 3 |
common | method | 3 |
more | data | 3 |
clinical | results | 3 |
mean | levels | 3 |
- | aging | 3 |
- | method | 3 |
- | studied | 3 |
bacterial | group | 3 |
chronic | infections | 3 |
clinical | copd | 3 |
- | aged | 3 |
different | methods | 3 |
different | results | 3 |
high | exacerbation | 3 |
higher | lung | 3 |
human | copd | 3 |
important | method | 3 |
mean | % | 3 |
different | patients | 3 |
older | patient | 2 |
positive | exacerbations | 2 |
positive | cells | 2 |
other | treatments | 2 |
other | disease | 2 |
other | cases | 2 |
other | age | 2 |
normal | patients | 2 |
older | groups | 2 |
obstructive | disease | 2 |
normal | response | 2 |
normal | level | 2 |
normal | cell | 2 |
more | years | 2 |
positive | studies | 2 |
positive | groups | 2 |
significant | level | 2 |
primary | disease | 2 |
primary | level | 2 |
primary | studies | 2 |
pulmonary | effects | 2 |
respiratory | effects | 2 |
respiratory | group | 2 |
significant | exacerbations | 2 |
significant | factors | 2 |
more | patient | 2 |
such | exacerbations | 2 |
such | factor | 2 |
such | results | 2 |
such | study | 2 |
viral | group | 2 |
viral | studies | 2 |
more | risk | 2 |
such | factors | 2 |
more | asthma | 2 |
chronic | age | 2 |
different | times | 2 |
different | data | 2 |
common | infection | 2 |
common | group | 2 |
common | airway | 2 |
clinical | responses | 2 |
acute | treatment | 2 |
epithelial | airway | 2 |
acute | infections | 2 |
acute | diseases | 2 |
acute | disease | 2 |
- | factors | 2 |
- | case | 2 |
more | airway | 2 |
different | treatments | 2 |
chronic | treatment | 2 |
epithelial | infection | 2 |
important | treatment | 2 |
medical | treatments | 2 |
high | lung | 2 |
mean | times | 2 |
mean | responses | 2 |
lower | exacerbation | 2 |
inflammatory | exacerbations | 2 |
medical | studies | 2 |
important | group | 2 |
important | effect | 2 |
important | disease | 2 |
important | cells | 2 |
higher | risks | 2 |
higher | infection | 2 |
old | group | 1 |
more | lung | 1 |
more | treatment | 1 |
normal | aging | 1 |
normal | copd | 1 |
normal | group | 1 |
old | disease | 1 |
older | data | 1 |
old | methods | 1 |
older | asthma | 1 |
other | infections | 1 |
oldest | patients | 1 |
other | ages | 1 |
other | care | 1 |
other | factor | 1 |
more | group | 1 |
more | groups | 1 |
mean | risk | 1 |
more | exacerbation | 1 |
medical | data | 1 |
mean | days | 1 |
mean | infection | 1 |
mean | resulting | 1 |
other | responses | 1 |
mean | treatment | 1 |
mean | years | 1 |
medical | cases | 1 |
medical | diseases | 1 |
more | effect | 1 |
medical | factors | 1 |
medical | response | 1 |
more | cases | 1 |
more | copd | 1 |
more | days | 1 |
more | disease | 1 |
more | diseases | 1 |
other | level | 1 |
respiratory | exacerbation | 1 |
others | exacerbation | 1 |
significant | copd | 1 |
significant | lung | 1 |
significant | study | 1 |
such | age | 1 |
such | cells | 1 |
such | effect | 1 |
such | effects | 1 |
such | groups | 1 |
such | methods | 1 |
such | result | 1 |
viral | airway | 1 |
viral | cell | 1 |
viral | diseases | 1 |
viral | levels | 1 |
viral | lung | 1 |
lowest | level | 1 |
significant | factor | 1 |
significant | age | 1 |
others | groups | 1 |
severest | cases | 1 |
others | studies | 1 |
positive | airways | 1 |
positive | patient | 1 |
positive | responses | 1 |
primary | infection | 1 |
primary | patients | 1 |
pulmonary | airways | 1 |
pulmonary | cases | 1 |
pulmonary | cell | 1 |
pulmonary | group | 1 |
pulmonary | patients | 1 |
pulmonary | treatment | 1 |
severe | levels | 1 |
severe | p | 1 |
severe | response | 1 |
lowest | levels | 1 |
different | p | 1 |
lower | response | 1 |
common | treatment | 1 |
clinical | patient | 1 |
clinical | time | 1 |
common | asthma | 1 |
common | cases | 1 |
common | lung | 1 |
common | methods | 1 |
common | response | 1 |
different | airway | 1 |
lower | disease | 1 |
different | asthma | 1 |
different | case | 1 |
different | effect | 1 |
different | exacerbation | 1 |
different | level | 1 |
different | risk | 1 |
different | risks | 1 |
clinical | infection | 1 |
clinical | groups | 1 |
clinical | group | 1 |
clinical | exacerbations | 1 |
- | data | 1 |
- | effect | 1 |
- | exacerbation | 1 |
- | levels | 1 |
- | timed | 1 |
- | treatments | 1 |
acute | airway | 1 |
acute | effect | 1 |
bacterial | disease | 1 |
bacterial | groups | 1 |
bacterial | lung | 1 |
chronic | care | 1 |
chronic | responses | 1 |
clinical | asthma | 1 |
clinical | case | 1 |
different | studied | 1 |
different | study | 1 |
epithelial | response | 1 |
human | age | 1 |
human | data | 1 |
human | study | 1 |
humans | responses | 1 |
immune | lung | 1 |
important | copd | 1 |
important | data | 1 |
important | infection | 1 |
important | lung | 1 |
important | results | 1 |
inflammatory | exacerbation | 1 |
inflammatory | group | 1 |
inflammatory | treatment | 1 |
low | patient | 1 |
low | patients | 1 |
low | response | 1 |
human | cases | 1 |
highest | level | 1 |
epithelial | responses | 1 |
highest | copd | 1 |
high | case | 1 |
high | cell | 1 |
high | group | 1 |
high | infection | 1 |
high | patient | 1 |
high | response | 1 |
high | results | 1 |
higher | % | 1 |
higher | age | 1 |
higher | airway | 1 |
higher | case | 1 |
higher | cell | 1 |
higher | disease | 1 |
higher | patient | 1 |
higher | response | 1 |
viral | response | 1 |